(Q33337771)
Statements
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies (English)
Tetef ML
Synold TW
Chow W
Leong L
Margolin K
Morgan R
Raschko J
Shibata S
Somlo G
Yen Y
Groshen S
Johnson K
Lenz HJ
Gandara D